MedTech
Update on the EU MDR delay and impact on industry - Panel discussion
![](https://knect365.imgix.net/uploads/cc081412-5ada-44d7-862c-f9ef995540f0-featured-af256e401458460d213c3c255400d655.png?auto=format&fit=max)
With confirmation of the EU MDR delay due to COVID-19, MedTech Summit brought together four industry insiders to discuss the update and the impacts it will have on industry. The video discussion features:
- Gert Bos, Executive Director & Partner at Qserve Group, The Netherlands
- Annabelle Bruydonckx, Counsel at Simmons & Simmons LLP, Belgium
- James Whitehead, Patient Safety Medical Device Lead at AstraZeneca, UK
- Vladimir Murovec, Supervising Associate (Healthcare & Life Sciences) at Simmons & Simmons, Belgium
Rebecca Brady, Senior Conference Producer at Informa Life Sciences, led the discussion, which you can watch in full below (or here):